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Functional analysis of human and chimpanzee promoters <p>Twelve promoters of genes differentially expressed between humans and chimpanzees were tested for expression activity in culture  cells. Seven promoters showed a significant difference in expression level between the human and chimpanzee promoter, but only three  were in the same direction as the tissues, indicating that relevant expression differences between humans and chimpanzees will be difficult  to predict from cell culture experiments or DNA sequences</p>
Abstract
Background: It has long been argued that changes in gene expression may provide an additional
and crucial perspective on the evolutionary differences between humans and chimpanzees. To
investigate how often expression differences seen in tissues are caused by sequence differences in
the proximal promoters, we tested the expression activity in cultured cells of human and
chimpanzee promoters from genes that differ in mRNA expression between human and
chimpanzee tissues.
Results: Twelve promoters for which the corresponding gene had been shown to be differentially
expressed between humans and chimpanzees in liver or brain were tested. Seven showed a
significant difference in activity between the human promoter and the orthologous chimpanzee
promoter in at least one of the two cell lines used. However, only three of them showed a
difference in the same direction as in the tissues.
Conclusion: Differences in proximal promoter activity are likely to be common between humans
and chimpanzees, but are not linked in a simple fashion to gene-expression levels in tissues. This
suggests that several genetic differences between humans and chimpanzees might be responsible
for a single expression difference and thus that relevant expression differences between humans
and chimpanzees will be difficult to predict from cell culture experiments or DNA sequences.
Background
Thirty years ago, King and Wilson [1] proposed that pheno-
typic differences between humans and chimpanzees are
mainly caused by quantitative changes in gene expression
rather than by structural changes in gene products. This idea
is promoted also in some reviews [2] and seems to be sup-
ported by recent studies [3-8], which show that as many as
10% of all genes expressed in the brain differ in their expres-
sion levels between humans and chimpanzees. However, a
causative connection between phenotypic differences and
gene-expression differences in the two species remains to be
established [9]. Similarly, the molecular basis of gene-expres-
sion differences between the two species is largely unknown.
The regulation of gene expression is a complex process
involving chromatin structure, DNA methylation, transcrip-
tion initiation, alternative splicing, RNA degradation, trans-
lational control, and posttranslational modifications [10,11].
However, initiation of transcription is thought to be a major
factor determining the level of gene expression in most
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systems [12,13]. Studies in maize, yeast, mice, rats and
humans indicate that both cis- and trans-acting factors are
involved in transcriptional regulation [14-21]. Although
trans-acting factors are clearly important, allelic DNA
sequence variation in several human promoters has been
shown to profoundly influence transcriptional activity [22-
26]. Furthermore, the only functional comparison of a human
and a chimpanzee promoter published to date shows that
three nucleotide differences can lead to large differences in
promoter activity [27].
To estimate what fraction of mRNAs differently expressed
between human and chimpanzee tissues may be caused by
DNA sequence differences in core promoters, we analyzed the
activity of human and chimpanzee promoters from 12 genes
that differ in their mRNA expression between the two species
in brain and liver as measured by microarrays [6]. In each
case, 2 kilobases (kb) of the putative human and chimpanzee
promoter regions were cloned and tested for their ability to
drive the transcription of a reporter gene during transient
expression in human cervical carcinoma and neuroblastoma
cell lines. The results show that no simple relationship exists
between in vitro promoter activity and mRNA levels in tis-
sues of the organisms.
Results
Gene-expression data measured with Affymetrix U95A arrays
from livers and the prefrontal cortex of the brains of three
humans and three chimpanzees [6] were used to identify
genes that differ significantly in expression between the spe-
cies. To avoid the influence of sequence differences on the
hybridization of chimpanzee transcripts to microarray probes
designed for human transcripts, we excluded all probes show-
ing inconsistent hybridization patterns in the two species as
described elsewhere [8]. The genes were required to be differ-
entially expressed in at least one of the two tissues with a
magnitude of at least 1.4-fold (false-discovery rate < 1%). The
71 genes that satisfied these criteria were further selected on
the basis of the availability of an annotated transcription start
site [28], the availability of human and chimpanzee DNA
sequence of high quality, the possibility to place primers for
amplification of the promoters as well as the successful
amplification and cloning of the promoter fragments (see
Materials and methods).
This left us with human and chimpanzee promoters from 12
genes. From each promoter, a fragment covering approxi-
mately 1,500 base pairs (bp) upstream and ≤  500 bp down-
stream of the transcription start site without including the
start codon was cloned in a plasmid in front of a firefly luci-
ferase reporter gene. For each species, three independent
clones were isolated and the insert of each clone was
sequenced in its entirety. Each plasmid was mixed with a
plasmid containing a sea-pansy luciferase reporter gene
under the control of a constitutive promoter and transfected
into a human neuroblastoma cell line and a human cervical
carcinoma cell line, respectively. Experiments were per-
formed in triplicate and the activities of the two luciferases
were measured. All constructs showed an activity at least
ninefold higher than the promoter-less control vector in at
least one of the two cell lines. To control for transfection effi-
ciency, the measurement of the firefly luciferase was normal-
ized to the measurement of the sea-pansy luciferase and the
difference in activity between the three human clones and the
three chimpanzee clones analyzed.
The results are summarized in Figure 1 and Table 1. Out of the
12 promoters tested, two (ACADSB, C10orf10) show a signif-
icant difference (ANOVA p-value < 0.05) in both cell lines
whereas five (IMPA1, CGI-51, SH3BGR, UNG, TERF) show a
significant difference in only one of the two cell lines. Five
promoters show no significant difference in either cell line.
The average sequence divergence (Table 1) for these five pro-
moters (1.2%) and the remaining seven (1.3%) is not signifi-
cantly different from each other, neither for the complete
promoter fragment (two-tailed t-test, p = 0.65) nor for 220 bp
around the transcription start site (p = 0.43) in which most of
the conserved regulatory motifs are found [29]. One pro-
moter (THEM2) contains a chimpanzee-specific Alu inser-
tion, but does not show a significant difference in its activity
in either of the two cell lines.
Three promoters (ACADSB, C10orf10, IMPA1) show activity
differences in the promoter assays that go in the same direc-
tion as the expression differences of the corresponding genes
in the tissues. Interestingly, the two promoters (ACADSB,
C10orf10) that show qualitatively similar differences in the
two cell lines are both in concordance with the tissue expres-
sion differences. For four promoters (CGI-51, SH3BGR, UNG,
TERF) that show differences in only one of the cell lines, the
difference goes in the opposite direction to the expression dif-
ferences in the tissues.
Discussion
We have compared the transcriptional activity of human and
chimpanzee promoters from 12 genes that differ in their
expression levels between humans and chimpanzees in tis-
sues. We find that seven of the 12 promoter pairs differ signif-
icantly in their transcriptional activity in at least one of the
two cell lines used (Figure 1, Table 1). This is in agreement
with the finding that many proximal promoters that show
sequence differences among humans differ in their activity in
promoter assays [22,25,26,30]. Furthermore, we find that in
five cases promoter activity differences are restricted to one of
the two cell lines, showing that interspecies differences in
promoter activity are often specific to cell line or tissue, an
observation that is compatible with previous work on allelic
promoter differences among different human cell lines
[22,26] and tissue-specific cis-acting variation in mice [31]
and humans [32]. Clearly, in order to predict such differenceshttp://genomebiology.com/2005/6/7/R57 Genome Biology 2005,     Volume 6, Issue 7, Article R57       Heissig et al. R57.3
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in promoter activity from their DNA sequences, much more
knowledge on the occurrence of transcription factors in cells
and their binding sites in vivo is needed.
What might seem more unexpected is that the differences in
promoter activity observed in the cell lines seem to be inde-
pendent of the differences in expression seen in the tissues.
The transcript levels of only three genes (ACADSB, C10orf10,
IMPA1) go in the same direction in at least one of the cell lines
as they do in the tissues, whereas they go in the opposite
direction for four genes (CGI-51, SH3BGR, UNG, TERF) in
one of the two cell lines. One possible explanation is that the
expression differences observed in tissues are due to differ-
ences in environmental factors between the species. This,
however, seems unlikely, given the high reproducibility of
expression differences between studies [5,33] that use differ-
ent individuals. Assuming that the observed expression dif-
ferences in tissues are indeed genetic in nature, one
possibility to account for the discrepancy with the promoter
activities observed in vitro is that the same sequence differ-
ences in the proximal promoters have opposite effects in dif-
ferent tissues or cell lines. However, none of the 12 promoters
tested showed a significant opposite effect in the two cell lines
(Figure 1), nor did any of 43 allelic variants of human promot-
ers tested in a previous study show an opposite effect in dif-
ferent cell lines [22,26]. Furthermore, over 99% of the genes
that show a significant expression difference between
humans and chimpanzees in two tissues show the same direc-
tion of change in the two tissues [6,34]. Thus, it seems
unlikely that a tissue- or cell-type effect is responsible for the
opposite expression patterns seen here between the cell lines
and the tissues.
A remaining possibility is that additional genetic differences
between humans and chimpanzees outside the proximal pro-
moters are numerous and/or strong enough to lead to gene-
expression levels in tissues that are often qualitatively oppo-
site to what would be inferred from the activity of the proxi-
mal promoter in vitro. This agrees with the observation that
many gene-expression differences are inherited as quantita-
tive traits, that is, several genetic loci are responsible for
allelic gene expression differences observed among humans
Human and chimpanzee promoter activity and mRNA expression in tissues Figure 1
Human and chimpanzee promoter activity and mRNA expression in tissues. (a) Promoter activity in cell cultures. Normalized activities of promoters of 
the indicated genes are compared to the average of the three human and the three chimpanzee clones for each cell line and promoter indicated. Blue 
indicates lower activity than average, whereas yellow indicates higher activity. The color scale for the fold-change is below. Significant differences in activity 
between the two species are indicated by red frames. (b) Expression of the genes in tissues as assayed by mRNA levels measured by oligonucleotide 
arrays for brain and liver [6]. The values are averages of the three human and three chimpanzee individuals for which expression levels were determined 
[6] and are compared to the average level of the corresponding gene.
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and among mice [14,21,35]. In fact, when gene-expression
differences between humans and chimpanzees are compared,
the number of loci affecting the expression of single genes is
likely to be even higher than for allelic differences, as these
two species are more diverged than individual mice or
humans. Of possible relevance in this respect is the recent
finding that promoters are much less conserved, relative to
intronic regions, between human and chimpanzee than
between mouse and rat [36]. A probable cause of this is the
smaller effective population size of primates than of rodents,
which would have allowed slightly deleterious regulatory var-
iants to become fixed in periods when the population size was
small [36]. When the population size, and hence the effective-
ness of selection, subsequently increased, compensatory
mutations outside the proximal promoters might have
become fixed. An example of such compensatory mutations
has been described for the even-skipped stripe 2 enhancer in
two Drosophila species [37].
It is worth noting that the genes studied here are all differen-
tially expressed in human and chimpanzee tissues. It is still
unclear to what extent the discordance between behavior of
promoters in vitro and the corresponding tissue mRNA levels
also holds true for genes that do not show an expression dif-
ference between human and chimpanzee tissues. If many
genetic differences do indeed influence the expression of a
single gene, the proximal promoters of these non-differen-
tially expressed genes would be expected to differ in their
activity almost as frequently as the promoters of differentially
expressed genes.
Our results imply that although many promoters may differ in
activity between humans and chimpanzees, it will be difficult
to predict physiologically relevant gene-expression
differences from promoter activities observed in cell lines,
even between two closely related species such as humans and
chimpanzees. Further work is necessary to elucidate to what
extent this applies also to allelic DNA sequence differences in
promoters observed within a species. Further work is also
needed to elucidate whether a general paradigm for how
genome structure translates to gene expression activity can be
derived.
Materials and methods
Selection of promoters for study
Genes for promoter analysis were selected on the basis of a
large-scale transcriptome comparison between three humans
and three chimpanzees in brain and liver using Affymetrix
HG U95A and HG U95Av2 arrays [6]. All microarray analysis
was performed using the MAS 5.0 software package from
Affymetrix. Selected genes were required to be differentially
expressed in at least one of the two tissues with average
change p-value < 0.05 or > 0.95 (two-sided test) and with a
fold-change magnitude of at least 1.4-fold. The false-discov-
ery rate was determined by applying these selection criteria to
10,000 permutations of the original dataset with randomly
assigned sample labels. Expression differences were con-
firmed by masking all probes showing inconsistent hybridiza-
tion patterns in the two species using a custom mask file as
described elsewhere [8].
Table 1
DNA sequence and expression divergence of human and chimpanzee promoters
Promoter Divergence† Divergence TSS‡ Brain§ Liver§ Neuroblastoma¶ Cervical carcinoma¶
ACADSB 1.4 3.3 -1.6 -1.3 -0.5* -0.3*
C10orf10 1.3 1.8 ND 4.0 1.4** 0.7***
CGI-51 1.6 1.9 -0.4 -1.3 0.3* 0.1
DDX17 1.8 2.0 -4.2 -4.4 0 -0.1
DHX16 1.5 0.9 -0.8 -1.7 0 0.1
HLA-DPB1 0.8 0.9 2.5 4.1 0.2 0.2
IMPA1 1.5 2.6 2.3 2.6 0.6* 0.2
PCOLCE 0.9 0.6 ND 2.1 0 0.2
SH3BGR 1.6 1.3 1.9 2.4 -0.8 -0.7***
TERF1 1.5 1.4 2.3 1.6 -0.7* 0
THEM2 1.2 2.6 -0.5 -0.8 0.1 0.1
UNG 0.6 0.5 2.5 1.8 -0.3* 0
†Point substitutions per compared site in the whole promoter (~ 2 kbp); ‡point substitutions per compared site around the transcription start site (-
200 to +20); §signal log2 ratio as determined from arrays, where positive values indicate higher expression in humans (that is, a value of 1 means 
twofold higher expression in humans); ¶average signal log2 ratio for the promoter activity in cell lines; *, ** and *** indicate p-values (ANOVA) < 
0.05, 0.01, and 0.001, respectively.http://genomebiology.com/2005/6/7/R57 Genome Biology 2005,     Volume 6, Issue 7, Article R57       Heissig et al. R57.5
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We used the DBTSS databases of transcriptional start sites
[38] (August 2003) to identify the transcription start sites
and to collect promoter sequences 2,000 bp upstream and
1,000 bp downstream of the start sites. Out of a total of 71
genes satisfying the gene-expression-based criteria (see Addi-
tional data file 1), 35 had annotated transcription start sites
and chimpanzee sequence was available (July 2003). For 24
of them, primers were designed using Primer 3 software [39]
to amplify approximately 1,500 bp upstream and 500 bp
downstream of the transcription start site, if possible without
including any coding sequence or the start codon. Restriction
sites for BglII or XhoI (depending on the presence of restric-
tion sites in the promoter sequence) were added to the 5'-end
of the primer for cloning. Using these primers (see Additional
data file 2), we were able to amplify and isolate three inde-
pendent clones from both species for 12 genes.
Cloning and reporter gene assay
DNA from one human and one chimpanzee was amplified
using Expand 20 kb Plus PCR system (Roche) according to
the manufacturer's protocols with an extension time of 3 min,
or Pfu DNA polymerase (Stratagene), using the following con-
ditions: 1 min at 96°C, 45 sec at 96°C, 45 sec at 61°C, 5 min at
72°C for 38 cycles, followed by a final extension at 72°C for 10
min, on Tetracyclers (MJ Research).
P C R  p r o d u c t s  w e r e  p u r i f i e d  u p  b y  Q I A q u i c k  e i g h t - w e l l
cleanup kit (Qiagen), digested with either BglII (NEB) or
XhoI (NEB), purified on 1% low-melting agarose gels
(Promega) and isolated using QIAquick gel purification kit
(Qiagen). These fragments were cloned upstream of the firefly
luciferase gene into the BglII or XhoI site of the pGl3 vector
(Promega), using T4 Quick Ligase (NEB) and One Shot Top
10 F cells (Invitrogen). Colonies were picked and heated in 10
µl water for 5 min at 96°C, and 2 µl was used as template in a
25 µl PCR reaction, using one primer in the vector (GL2) and
one primer in the promoter.
Positive clones were grown in 7 ml LB medium (Invitrogen)
containing 100 µg/ml ampicillin (Sigma) at 37°C overnight.
Vector DNA was isolated using a Miniprep kit (Qiagen), and
DNA concentration was measured on a Nanodrop UV spec-
trophotometer (NanoDrop Technologies). All inserts were
sequenced (Additional data file 4) using Big Dye Terminator
chemistry (Applied Biosystems).
The human neuroblastoma cell line (SHEP [27]) was
obtained from Martin Reick, University of Texas Southwest-
ern Medical Center, and the human cervical carcinoma cell
line (c33a) (ATCC Number HTB-31) was obtained from Kurt
Engeland, University of Leipzig. SHEP cells were grown in
DMEM (Gibco) medium supplemented with 15% fetal bovine
serum (Sigma) and c33a cells in DMEM/MIX F12 (Gibco)
supplemented with 10% fetal bovine serum (Sigma), and
plated at ~85% confluence a day before transfection. One
microgram of the promoter constructs was mixed with 67.4
ng of the pRL-SV40 vector (Promega) containing the sea-
pansy luciferase gene in 96.8 µl serum-free medium
(Optimem1, Gibco) and 2.5 µl Lipofectamine 2000 (Gibco).
Cells were transfected in triplicate for 4 h at 37°C, 5% CO2 and
100% humidity, grown for 20 h and then lysed in 100 µl lysis
buffer (Promega).
A 5 µl sample of lysate was used in a Dual-Luciferaser
Reporter Assay System (Promega) in a Wallac Victor 2 Lumi-
nometer (PerkinElmer). Promoter activity was measured by
normalizing the luciferase activity of the promoter constructs
to the sea-pansy luciferase activity of the control plasmid
from the same well (see Additional data file 3). We assessed
the significance (p < 0.05) of different activity in human and
chimpanzee promoters using a multi-way ANOVA including
species, clones, and replicates.
Additional data files
Additional data is available with the online version of this
paper. Additional data file 1 is a table listing the 71 genes dif-
ferentially expressed between humans and chimpanzees in
liver and/or brain. For the probe sets the change p-values
(MAS 5.0) averaged over the 36 pairwise comparisons
between human and chimpanzee samples [6] and the signal
log2 ratio (slr; MAS 5.0) for the probe sets are given. p-values
close to 1 suggest a higher expression in chimpanzees, as does
a negative slr. Additional data file 2 is a table listing the
primers used for promoter amplification. Primer sequences
are written 5' to 3' and lower-case letters indicate added
restriction sites. Additional data file 3 is a table listing meas-
ured promoter activities (the measured luciferase activity of
the promoter constructs divided by the sea-pansy luciferase
activity, for each of the three replicates that were done for
each of the three clones for humans and chimpanzees in the
neuroblastoma cell line and the cervix carcinoma cell line,
respectively, for the 12 genes analyzed). Additional data file 4
contains the nucleotide sequences of the insert of the used
vectors.
Additional File 1 71 genes differently expressed between humans and chimpanzees  in liver and/or brain Supplementary Table 1: Listed are all 71 genes that were identified  as being at least 1.4-fold differently expressed in liver and/or brain.  For the probe sets the change p-values (MAS 5.0) averaged over the  36 pairwise comparisons between human and chimpanzee samples  [6] and the signal log2 ratio (slr; MAS 5.0) for the probe sets are  given. p-values close to 1 suggest a higher expression in chimpan- zees, as does a negative slr. Click here for file Additional File 2 Primers used for promoter amplification Supplementary Table 2: The primer sequences used to amplify the  promoter fragments are given here. Primer sequences are written  5' to 3' and lower-case letters indicate added restriction sites. Click here for file Additional File 3 Measured promoter activities Supplementary Table 3: The normalized promoter activities are  listed; that is, the measured luciferase activity of the promoter con- structs divided by the sea-pansy luciferase activity, for each of the  three replicates that were done for each of the three clones for  humans and chimpanzees in the neuroblastoma cell line and the  cervix carcinoma cell line, respectively, for the 12 genes analyzed. Click here for file Additional File 4 The nucleotide sequences of the cloned promoters The nucleotide sequences of the cloned promoters. Click here for file
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